Impact of GnRH antagonist pretreatment on oocyte yield after ovarian stimulation: A retrospective analysis
PLOS ONE · 2024
DOI: 10.1371/journal.pone.0308666 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS ONE, 2024. Verfasst von Di Guardo Federica und 8 weiteren Autor:innen. Beteiligte Einrichtung: Centre for Reproductive Medicine, Universitair Ziekenhuis Brussel, Vrije Universiteit Brussel, Brussels, Belgium. Hauptthemen laut MEDLINE: Gonadotropin-Releasing Hormone, Ovulation Induction, Oocytes. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Merck KGaA.
Abstract (Originalsprache)
The study investigates whether a 3-day pretreatment course with a GnRH antagonist in the early follicular phase has an impact on the number of retrieved COCs in a GnRH antagonist stimulation protocol. This is a retrospective single center crossover study involving women who did not conceive after one GnRH antagonist stimulation cycle (“standard cycle”) and proceeded with another GnRH antagonist stimulation cycle preceded by early administration of GnRH antagonist for 3 days (“pretreatment cycle”) with fresh embryo transfer or frozen embryo transfer. 430 patients undergoing 860 cycles were included. The mean female age was 34.4 ± 4.8 years. Indications for fertility treatment included unexplained infertility (34.3%), male-factor infertility (33.3%), age (16.9%), PCOS (8.2%), tubal (4.7) and endometriosis (2.6%). All cycles were divided into two groups: group 1 (standard, 430 cycles) and group 2 (pretreatment, 430 cycles). The mean duration of stimulation was similar in both groups (10.3 vs 10.3 days, p = 0.28). The starting dose of gonadotropin (234.9 vs 196.8 IU, p
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Centre for Reproductive Medicine, Universitair Ziekenhuis Brussel, Vrije Universiteit Brussel, Brussels, Belgium.
- Department of General Surgery and Medical Surgical Specialties, University of Catania, Catania, Italy.
- Centre of Reproductive Medicine, Instituto Bernabeu Venezia, Martellago, Venezia, Italy.
- Embryolab, IVF Unit, Thessaloniki, Greece.
- Department of Obstetrics, Gynecology, Perinatology and Reproduction, Institute of Professional Education, Sechenov First Moscow State Medical University of the Ministry of Health of the Russian Federation, Moscow, Russi…
ORCID-Profile: Panagiotis Drakopoulos, Christophe Blockeel
Förderung
- Merck KGaA
Zitieren
APA
Federica, D. G., De Rijdt, S., Racca, A., Drakopoulos, P., Mackens, S., Strypstein, L., Tournaye, H., De Vos, M., & Blockeel, C. (2024). Impact of GnRH antagonist pretreatment on oocyte yield after ovarian stimulation: A retrospective analysis. PLOS ONE. https://doi.org/10.1371/journal.pone.0308666
Vancouver
Federica DG, De Rijdt S, Racca A, Drakopoulos P, Mackens S, Strypstein L, et al. Impact of GnRH antagonist pretreatment on oocyte yield after ovarian stimulation: A retrospective analysis. PLOS ONE. 2024. doi:10.1371/journal.pone.0308666
BibTeX
@article{Federica2024,
author = {Federica, Di Guardo and De Rijdt, Sylvie and Racca, Annalisa and Drakopoulos, Panagiotis and Mackens, Shari and Strypstein, Laurence and Tournaye, Herman and De Vos, Michel and Blockeel, Christophe},
title = {Impact of GnRH antagonist pretreatment on oocyte yield after ovarian stimulation: A retrospective analysis},
journal = {PLOS ONE},
year = {2024},
doi = {10.1371/journal.pone.0308666}
}
EUVIMED